DrugsControl Media Services
DrugsControl.org

News Detail

Agilus Diagnostics launches Claudin 18.2 for advanced stomach cancer detection (03-12-2024)

Mumbai, 3 Dec 2024: Agilus Diagnostics announced the launch of the Claudin 18.2 test, a ground-breaking diagnostic tool.

 

The Claudin 18.2 test is a diagnostic tool, that offers precise identification of the Claudin 18.2 protein, a crucial biomarker for gastric, pan......
View Details

Source : Agilus Diagnostics
cancer diagnosis Claudin 18.2 test Agilus Diagnostics gastric cancer biomarker for cancer targeted therapies personalized medicine zolbetuximab-clzb

Related News